Crucial considerations: Sex differences in the epidemiology, diagnosis, treatment, and outcomes of acute pulmonary embolism in non‐pregnant adult patients

Acute pulmonary embolism (PE) affects over 600,000 Americans per year and is a common diagnostic consideration among emergency department patients. Although there are well‐documented differences in the diagnosis, treatment, and outcomes of cardiovascular conditions, such as ischemic heart disease an...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American College of Emergency Physicians Open Vol. 2; no. 1; pp. e12378 - n/a
Main Authors Jarman, Angela F., Mumma, Bryn E., Singh, Kajol S., Nowadly, Craig D., Maughan, Brandon C.
Format Journal Article
LanguageEnglish
Published United States John Wiley and Sons Inc 01.02.2021
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Acute pulmonary embolism (PE) affects over 600,000 Americans per year and is a common diagnostic consideration among emergency department patients. Although there are well‐documented differences in the diagnosis, treatment, and outcomes of cardiovascular conditions, such as ischemic heart disease and stroke, the influence of sex and gender on PE remains poorly understood. The overall age‐adjusted incidence of PE is similar in women and men, but women have higher relative rates of PE during early and mid‐adulthood (ages 20–40 years); whereas, men have higher rates of PE after age 60 years. Women are tested for PE at far higher rates than men, yet women who undergo computed tomography pulmonary angiography are ultimately diagnosed with PE 35%–55% less often than men. Among those diagnosed with PE, women are more likely to have severe clinical features, such as hypotension and signs of right ventricular dysfunction. When controlled for PE severity, women are less likely to receive reperfusion therapies, such as thrombolysis. Finally, women have more bleeding complications for all types of anticoagulation. Further investigation of possible sex‐specific diagnostic and treatment algorithms is necessary in order to more accurately detect and treat acute PE in non‐pregnant adults.
Bibliography:BEM has received investigator‐initiated research funding from Bristol Myers Squibb and Roche Diagnostics. BCM is supported by NIH 5K12HL133115. Other authors have no relevant or financial conflicts of interest to disclose.
Supervising Editor: Marna Rayl Greenberg, DO, MPH.
Funding and support
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Funding and support: BEM has received investigator‐initiated research funding from Bristol Myers Squibb and Roche Diagnostics. BCM is supported by NIH 5K12HL133115. Other authors have no relevant or financial conflicts of interest to disclose.
ISSN:2688-1152
2688-1152
DOI:10.1002/emp2.12378